Summary:
A 26-week randomized, double-blind, active controlled study comparing the safety of mometasone furoate/formoterol fumarate mdi fixed dose combination versus mometasone furoate mdi monotherapy in adolescents and adults with persistent asthma.
Qualified Participants Must:
• Be at least 12 years of age
•
Be diagnosed with persistent Asthma for at least a year
•
Be on at least one Asthma medication for at least 4 weeks
•
Hhave had Asthma exacerbation once in the past year
Qualified Participants May Receive:
Trial medications and investigations at no cost, and compensation for time and travel.